Zorevunersen

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameZorevunersen
Drug Alias NameSTK-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type I alpha subunit stimulants
TargetsSodium channel protein type I alpha subunit
Therapy Area/IndicationsEpilepsies, Myoclonic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyGermany +[8] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesStoke Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStoke Therapeutics IncBiogen Inc
Inactive CompaniesN/A
Active IndicationsEpilepsies, Myoclonic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank